Centiva Capital’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.71M Buy
161,400
+111,400
+223% +$1.56M 0.02% 378
2026
Q1
$596K Buy
+50,000
New +$718K ﹤0.01% 765
2025
Q4
– Sell
-1,320,500
Closed -$28.6M – 1558
2025
Q3
$28.6M Sell
1,320,500
-473,500
-26% -$10.6M 0.27% 67
2025
Q2
$39.9M Buy
1,794,000
+796,000
+80% +$17.7M 0.65% 21
2025
Q1
$23.7M Buy
+998,000
New +$23.6M 0.72% 13

Other funds holding SGRY

Centiva Capital's SGRY Position: Q2 2026 in Review

Centiva Capital reduced its Surgery Partners (SGRY) stake by 98% in Q2 2026, selling an estimated $2.9M and leaving 5,000 shares worth $84K. The position accounts for ﹤0.01% of the portfolio, ranked #1547.

Centiva Capital first reported a position in SGRY in Q2 2023 and has held it in 10 quarters since. The position peaked at $2.52M in Q1 2026. 187 funds tracked by Wall St. Rank hold SGRY as of Q2 2026.

  • Centiva Capital held 5,000 shares of Surgery Partners worth $84K as of Q2 2026.
  • Centiva Capital sold 206,299 Surgery Partners shares in Q2 2026, an estimated $2.9M.
  • Surgery Partners made up ﹤0.01% of Centiva Capital's portfolio in Q2 2026, its #1547 holding.
  • Centiva Capital first reported a position in Surgery Partners in Q2 2023 and has held it in 10 quarters since.
  • Centiva Capital's Surgery Partners position peaked at $2.52M in Q1 2026.
  • 187 funds tracked by Wall St. Rank held Surgery Partners as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.